State of knowledge about PCDH19
Initial findings from the Italian RESIDRAS: advantages and complexities in registries implementation
Cognitive and behavioural features in PCDH19
Study Proposal on Therapy Approaches, Effective Treatments, and Therapy Discontinuation
Genotype-Phenotype complexities of PCDH19 variation
Roles of the epilepsy-related protein PCDH19 during cortical development
Altered cytoskeleton dynamics in patient-derived iPSC-based model of PCDH19 clustering epilepsy
Studying interneuron development in Protocadherin-19 Clustering Epilepsy using mouse and brain organoid models
Assessing precision medicine strategies for PCDH19-Clustering Epilepsy using preclinical mouse models
Targeting Mosaicism in PCDH19 Epilepsy: Development of an ASO Therapy to Silence X-Linked Expression
Federico Vigevano (Director of Neuroscience DPT, Bambino Gesù Children's Hospital of Rome)
Simona Balestrini (Professor at Neuroscience Department, Children's Hospital A. Meyer-University of Florence)
Sara Mazzoleni, Giorgia Giansante, Maura Francolini, Mariaelvina Sala, Luca Murru, Silvia Bassani, and Maria Passafaro
Jack Parent (William J. Herdman Professor of Neurology and co-director of the Comprehensive Epilepsy Center at the University of Michigan Medical School)
Rebekah de Nys, Clare van Eyk, Raissa Relator, Rudrarup Bhattacharjee, Tarin Ritchie, Stefka Mincheva-Tasheva, Paul Thomas, Bekim Sadikovic, Raman Kumar and Jozef Gecz
Stefka Mincheva-Tasheva, Chandran Pfitzner, Michaela Scherer, Raman Kumar, Louise Robertson, Idha Kurtsdotter, Jonas Muhr, Jozef Gecz and Paul Q. Thomas
Silvia Landi and Gian Michele Ratto